We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGF icon
11576
Invesco Financial Preferred ETF
PGF
$668M
$247K ﹤0.01%
+12,789
New +$243K
PLXS icon
11577
PUT
Plexus
PLXS
$7.13B
$247K ﹤0.01%
2,700
-400
-13% -$37.5K
SCOR icon
11578
PUT
Comscore
SCOR
$94.1M
$247K ﹤0.01%
2,465
-1,745
-41% -$137K
UFOX
11579
PUT
Defiance Space and Connective Tech ETF
UFOX
$923M
$247K ﹤0.01%
6,500
-7,700
-54% -$282K
CASA
11580
CALL
DELISTED
Casa Systems, Inc. Common Stock
CASA
$247K ﹤0.01%
27,800
-8,300
-23% -$73.6K
CSII
11581
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
$247K ﹤0.01%
5,800
-1,600
-22% -$62.6K
JHB
11582
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
$247K ﹤0.01%
+26,235
New +$247K
AMRX icon
11583
PUT
Amneal Pharmaceuticals
AMRX
$6.32B
$246K ﹤0.01%
48,000
+34,200
+248% +$194K
CHRS icon
11584
CALL
Coherus Oncology
CHRS
$185M
$246K ﹤0.01%
17,800
-10,300
-37% -$146K
MIST icon
11585
CALL
Milestone Pharmaceuticals
MIST
$137M
$246K ﹤0.01%
44,800
+27,700
+162% +$157K
RIGL icon
11586
CALL
Rigel Pharmaceuticals
RIGL
$795M
$246K ﹤0.01%
5,670
+1,300
+30% +$49.1K
TGB
11587
PUT
Trekor Metals
TGB
$3.06B
$246K ﹤0.01%
116,200
+16,900
+17% +$36.3K
KBND
11588
DELISTED
KraneShares Bloomberg China Bond Inclusion Index ETF
KBND
$246K ﹤0.01%
7,081
-455
-6% -$16K
CFFVW
11589
DELISTED
CF Acquisition Corp. V Warrant
CFFVW
$246K ﹤0.01%
223,963
-200
-0.1% -$173
PROF
11590
PUT
Profound Medical
PROF
$241M
$245K ﹤0.01%
15,000
+1,800
+14% +$33.5K
RDVT icon
11591
Red Violet
RDVT
$1.12B
$245K ﹤0.01%
+10,392
New +$217K
RDW icon
11592
PUT
Redwire
RDW
$3.39B
$245K ﹤0.01%
+23,800
New +$241K
SCZ icon
11593
CALL
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$245K ﹤0.01%
3,300
TFIN icon
11594
PUT
Triumph Financial Inc
TFIN
$1.87B
$245K ﹤0.01%
3,300
-700
-18% -$59.6K
TGLS icon
11595
Tecnoglass Holdings
TGLS
$1.86B
$245K ﹤0.01%
11,448
-9,135
-44% -$151K
UNTY icon
11596
Unity Bancorp
UNTY
$621M
$245K ﹤0.01%
+11,089
New +$249K
ZKIN icon
11597
PUT
ZK International Group
ZKIN
$60.8M
$245K ﹤0.01%
+8,157
New +$310K
EPAY
11598
CALL
DELISTED
Bottomline Technologies Inc
EPAY
$245K ﹤0.01%
+6,600
New +$272K
RMGB
11599
CALL
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
$245K ﹤0.01%
+24,600
New +$245K
GAIN icon
11600
CALL
Gladstone Investment Corp
GAIN
$649M
$244K ﹤0.01%
+16,900
New +$236K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.